Healthcare Transforming healthcare through sustainable and resilient da... In the past two decades, global spending on health has doubled.
Articles Fixing the problems in bioinformatics Data management and analysis is increasingly important as the speed of genome sequencing increases and costs reduce.
News Chiesi signs $1.9bn deal to buy KalVista and its HAE drug Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
